Alterola Biotech, Inc. Stock Other OTC
Equities
ABTI
US02152V1035
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 35.27M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net Debt 2022 | 199K | Net Debt 2023 | 1.41M | EV / Sales 2023 | - |
P/E ratio 2022 |
-26.2
x | P/E ratio 2023 |
-20.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.4% |
Managers | Title | Age | Since |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 22-05-17 |
Timothy Rogers
CHM | Chairman | 60 | 21-06-20 |
Colin Stott
COO | Chief Operating Officer | 57 | 21-06-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 22-05-17 |
Nathan Thompson
BRD | Director/Board Member | - | 23-10-09 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
1st Jan change | Capi. | |
---|---|---|
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |